There were 452 press releases posted in the last 24 hours and 156,011 in the last 365 days.

PCR Markets 2019-2020 & Forecasts to 2024 - Point of Care Testing and Molecular Diagnostics are Merging

/EIN News/ -- Dublin, June 14, 2019 (GLOBE NEWSWIRE) -- The "PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024" report has been added to ResearchAndMarkets.com's offering.

Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets.

Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

Key Topics Covered:

1. Introduction and Market Definition
1.1 What are PCR Technologies?
1.2 PCR-New Horizons
1.2.1 PCR and Syndromic Testing
1.3 Market Definition
1.3.1 Market Size
1.3.2 Currency
1.3.3 Years
1.4 Methodology
1.5 U.S. Medical Market and laboratory Testing-Perspective
1.5.1 U.S. Medicare Expenditures for Laboratory Testing

2. PCR-Guide to PCR Technologies
2.1 Concepts
2.1.1 Method
2.2 Applications
2.2.1 Finding Specific DNA
2.2.2 Measuring DNA
2.2.3 Medical and diagnostic applications
2.2.3.1 Carrier, prenatal and tissue typing
2.2.3.2 Cancer Diagnosis and Management
2.2.3.3 Infectious disease-New Levels of Accuracy and Sensitivity
2.2.3.4 Forensic applications
2.2.3.5 Science and Research
2.3 PCR-Advantages and Disadvantages
2.4 Different Types of PCR
2.4.1 Simple Changes
2.4.1.1 Multiplex-PCR
2.4.1.2 VNTR PCR
2.4.1.3 Asymmetric PCR
2.4.1.4 Long PCR
2.4.1.5 Nested PCR
2.4.1.6 Quantitative PCR
2.4.1.7 Hot-start PCR
2.4.1.8 Touchdown PCR
2.4.1.9 Assembly PCR
2.4.1.10 Colony PCR
2.4.1.11 Suicide PCR
2.4.1.12 Cold PCR
2.4.2 Digital PCR
2.4.2.1 Droplet Digital PCR
2.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
2.4.2.3 Digital PCR in Use
2.4.2.4 Digital PCR Commercial History
2.4.3 Isothermal PCR

3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Genomic Instrumentation Supplier
3.1.3.1 Cell Separation and Viewing Instrumentation Supplier
3.1.4 Pharmaceutical/Reagent Supplier
3.1.5 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Lab
3.1.9 Audit Body
3.1.10 Certification Body

4. Market Trends
4.1 Factors Driving Growth
4.1.1 A New Standard
4.1.2 Down the Curve We Go
4.1.3 Multiplexing
4.1.4 Syndromic Diagnostics Looks Unstoppable
4.1.5 The Genetic Blizzard
4.2 Factors Limiting Growth
4.2.1 The Cost Curve
4.2.2 The Other Guys
4.2.3 Systemic Roadblocks
4.3 Diagnostic Technology Development
4.3.1 The Instrumentation Curve
4.3.2 Shifting Role of Diagnostics
4.3.3 Diagnostics Moves Out of the Lab
4.3.3.1 What About Imaging?
4.3.4 Disruption Looms
4.3.5 The Next Five Years

5. PCR Recent Developments
5.1 Recent Developments-Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section

  • QIAGEN Plans for Next-Generation Digital PCR Systems
  • Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
  • New PCR Technology: Transfer-PCR (tPCR) Applications
  • NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
  • Natera Applies Massively Multiplexed PCR to Kidney Transplants
  • Paragon Genomics, MGI Tech Form Distribution Alliance
  • Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
  • Qiagen, NeuMoDx Ink Partnership, Merger Agreement
  • Bruker to Acquire Majority in Hain Lifescience GmbH
  • Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
  • Cancer Early Detection Firm Ark Launches With $40M Series A Investment
  • PredictImmune Wins 100K Grant for Study of IBD Prognostic
  • Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
  • llumina Ventures Leads 16M Series A Investment in Digital PCR Firm Stilla Technologies
  • Bio-Rad Wins USDA Food Safety Testing Contract
  • Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal

6. Profiles of Key PCR Companies

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMrieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics.
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

7. The PCR Markets
7.1 PCR-Global Market Overview by Country

8. Global PCR Markets-By Application
8.1 Global Market by Application-Overview
8.2 PCR Clinical Multiplex
8.3 PCR Clinical Singleplex
8.4 PCR Research
8.5 PCR Forensic
8.6 PCR Other

9. Global PCR Markets-By Technology
9.1 Global Market by Technology-Overview
9.2 qPCR
9.3 dPCR
9.4 Other PCR

Appendices
I. United States Medicare System: 2018 Clinical Laboratory Fees Schedule-National Limit and Midpoint
II. FDA Approved Microbial Tests

For more information about this report visit https://www.researchandmarkets.com/r/n1kph

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics 

22157.jpg


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.